🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 09090D103 (prev. 15957A207 )
- Market Cap
- Small Cap
- IPO
- 3/13/2019 · $10.00/share
- Previous Symbol
- CHAC (changed 10/28/2019)
- Previous Name
- Chardan Healthcare Acquisition Corp.
Business: BiomX Inc. is a clinical stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as IBD, PSC, and cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.
Company Contact
- CEO
- Jonathan Solomon
- VPF
- Marina Wolfson
- Investor Relations
- assafo@biomx.com